600085.SH
Beijing Tong RenTang Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 24.69
−0.84%Oct 30, 2026, 09:46 UTC
Tong Ren Tang reported revenue of 11.059 billion yuan and net profit attributable to shareholders of 866 million yuan for the first three quarters of 2026.
Source:Oct 30, 2026, 09:46 UTC
Tong Ren Tang reported third-quarter 2026 revenue of 2.68 billion yuan, down 24.28% year over year, and net profit attributable to shareholders of 140 million yuan, down 39.87%.
Source:Oct 14, 2026, 08:45 UTC
Macau's Pharmaceutical Administration Bureau issued registration certificates permitting six Tong Ren Tang-branded medicines to be registered in Macau, with Beijing Tong Ren Tang (Macau) Limited as the registration holder.
Oct 8, 2026, 08:47 UTC
Hong Kong's Chinese Medicine Council issued a registration certificate permitting Beijing Tong Ren Tang Chinese Medicine Co., Ltd.'s Ding Zhi Wan to be sold in Hong Kong.
Sep 29, 2026, 07:44 UTC
Beijing Economic Development Investment Co. plans to exit Beijing Tongrentang Commercial Investment Group by a targeted capital reduction of its 9.6038% stake for RMB 246 million, raising Tongrentang's holding to 57.5033%.
Source:Sep 1, 2026, 05:53 UTC
Tongrentang International announced that Ji Guangfei stepped down as chairman and Li Jiang, formerly co-president, was appointed as the new chairman.
Aug 30, 2026, 07:58 UTC
Tong Ren Tang reported a net profit of 726.2 million yuan for the first half of the year, compared with 945.5 million yuan in the same period last year.
Jul 3, 2026, 01:52 UTC
Tongrentang Medical Care has priced its Hong Kong IPO at 5.50 Hong Kong dollars per share.
Source: